gland pharma glp-1 capacity expansion capex drug demand to drive growth, SCHOTT Glass India plans ₹150-crore expansion. Its facility in Jambusar, Gujarat, is the largest pharmaceutical tubing manufacturing site in India and the second largest globally. http://ow.ly/VYB9106okKB Eli Lilly's $1 Billion India

those with more advanced beta cell dysfunction may experience less benefit from GLP-1 therapy, as the medication relies on functional beta cells to stimulate insulin secretion

Second, during the evaluation visit, patients were asked at 8:00 am, 9:00 am, 12:00 pm, 1:00 pm, and 4:00 pm to indicate their current thirst perception on the 10-point NRS

"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist"

However, some aspects of GLP-1 receptor agonist science remain subject to ongoing investigation and debate: Signaling Bias: The concept of biased agonismthat a compound can selectively activate one signaling pathway over anotheris a relatively recent development in pharmacology

Large-scale trials comparing GLP-1 agonists alone to traditional treatments do not yet exist

Glutathione exists in two forms, the oxidized and reduced forms